Dear All,

In order to further research in the area of mRNA therapeutics, as well as in 
disease areas currently under investigation by Moderna, we are pleased to offer 
the opportunity to support research fellowships. These fellowships are intended 
to support research in a wide array of disciplines including pharmacometrics. 
The application process is intended to be as simple as possible, institutions 
apply with a named supervisor and fellow. The fellowship will be awarded for 
between 1 and 3 years, and will support salary costs and research expenses. The 
program will launch in 2022, and the deadline for applications is December 31st 
2021. Successful applications will be informed of the decision by March 31st 
2022.

To apply, please download and fill the application form below. Return your 
completed application to 
[email protected]<mailto:[email protected]>.

Application 
form<https://www.modernatx.com/sites/default/files/u2406/Moderna-GlobalFellowshipApplicationv4.pdf>

https://www.modernatx.com/research-fellowship

Regards,

Husain Attarwala, PhD
Director & Head, Clinical Pharmacology and Pharmacometrics | Moderna
mobile (617) 840-0805 | office (617) 803-3425 | 
modernatx.com<http://modernatx.com/>
 [signature_2127785708] <http://www.modernatx.com/>
[signature_1146048737]<http://facebook.com/modernatx/>     
[signature_118176511] <https://twitter.com/moderna_tx>      
[signature_1781966198] <http://youtube.com/user/ModernaTx>      
[signature_1489564253] <https://linkedin.com/company/moderna->



P Please consider the environment before printing this email


Confidentiality notice and disclaimer: The information in this message and any 
attachments is intended for the exclusive use of the addressee(s), is 
confidential and may be privileged or otherwise protected from disclosure. Any 
review, retransmission, dissemination or other use of, or taking of any action 
in reliance upon, of any such information by persons or entities other than the 
intended addressee(s) is prohibited. If you have received this message in error 
and are not the intended addressee, please notify the sender immediately and 
delete this message and any attachments from your system without reading or 
disclosing them. If you are not the intended addressee, be advised that any use 
of the information in this message and any attachment is prohibited and may be 
unlawful, and you must not copy this message or attachment or disclose the 
contents to any other person.

Reply via email to